The Prevalence and Trends of Hepatitis B, Hepatitis C, and HIV among Voluntary Blood Donors in Kohgiluyeh and Boyer-Ahmad Transfusion Center, Southwestern Iran
-
Seyed Mehdi SAJJADI
,
Ali Akbar POURFATHOLLAH
,
Saeed MOHAMMADI
,
Bijan NOURI
,
Rostam HASSANZADEH
,
Fariba RAD
Abstract
Background: Transfusion transmissible infections (TTIs) are a common complication of blood transfusion. Evaluation and monitoring the prevalence rate of TTIs in blood donors is a valuable indicator of donor selection and blood safety. We analyzed the trends of these infections among blood donors at Kohgiluyeh and Boyer-Ahmad transfusion service (KBTC) during 10 years.
Methods: Viral screening and confirmatory tests were carried out on 180304 voluntary donations from 2005-2014. The annual prevalence rates of hepatitis B virus (HBV), hepatitis C virus (HCV) and HIV infections per 100000 donations and 95% confidence interval were calculated. Chi-square test was applied to obtain the P-value.
Results: The overall prevalence was 0.13% for HBV and 0.06% for HCV while there were only three positive cases for HIV. The annual trend fluctuated during the time period studied. Compared to first-time donors, regular and repeat donors were significantly less likely to be positive for these infections. Outstandingly, this study provides first data in TTIs seropositivity rates among blood donors in our region; surprisingly were lower compared to other reports of Iran.
Conclusion: The trends of TTIs prevalence in this study provide additional evidence that safety measures employed by the KBTC have been effective in maintaining a safe blood supply. The lower prevalence of TTIs in our study compared with other Iranian studies and also the general population reflects the efficacy of donor selection and education procedures in KBTC.
Noubiap JJ, Joko WY, Nansseu JR et al. (2013). Sero-epidemiology of human immunodeficie-ncy virus, hepatitis B and C viruses, and syphilis infections among first-time blood donors in Edéa, Cameroon. Int J Infect Dis,17(10):e832-e837.
Kafi-Abad SA, Rezvan H, Abolghasemi H (2009). Trends in prevalence of hepatitis B virus infection among Iranian blood donors, 1998–2007. Transfus Med,19(4):189-194.
Mohammadali F, Pourfathollah AA (2014). Changes in Frequency of HBV, HCV, HIV and Syphilis Infections among Blood Donors in Tehran Province 2005–2011. Arch Iran Med,17(9):613-620.
Dilsiz G, Yenicesu I, Belen FB et al (2012). Trends in hepatitis B and hepatitis C virus seropositivity among blood donors over 15 years screened in the blood bank of a university hospital. Transfus Apher Sci, 47(1):95-100.
Meena M, Jindal T, Hazarika A.(2011) Prevalence of hepatitis B virus and hepatitis C virus among blood donors at a tertiary care hospital in India: a five year study. Transfusion, 51(1):198-202.
Hassanshahi G, Arababadi MK, Assar S et al (2011). Post-transfusion-transmitted hepatitis C virus infection: a study on thalassemia and hemodialysis patients in southeastern Iran. Arch Virol, 156(7):1111-1115.
Kafi-abad SA, Rezvan H, Abolghasemi H et al (2009). Prevalence and trends of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus among blood donors in Iran, 2004 through 2007. Transfusion, 49(10):2214-2220.
Alter MJ, Kruszon-Moran D, Nainan OV et al (1999). The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med, 341(8):556-562.
Glynn SA, Kleinman SH, Schreiber GB et al (2000). Trends in incidence and prevalence of major transfusion-transmissible viral infections in US blood donors, 1991 to 1996. JAMA, 284(2):229-235.
Matee MI, Magesa PM, Lyamuya EF (2006). Seroprevalence of human immunodeficiency virus, hepatitis B and C viruses and syphilis infections among blood donors at the Muhimbili National Hospital in Dar Es Salaam, Tanzania. BMC Public Health, 30;6:21.
ALGani FA (2011). International Journal of Biological and Medical Research. Int J Biol Med Res, 6 (1): 4709-4717.
Zheng X, Ding W, Li G et al (2015). Seroprevalence of transfusion-transmissible infectious agents among volunteer blood donors between 2006 and 2012 in Zhejiang, China. Blood Transfus, 13(3):401-410.
Bhawani Y, Rao PR, Sudhakar V (2010). Seroprevalence of transfusion transmissible infections among blood donors in a tertiary care hospital of Andhra Pradesh. Biol Med, 2(4):45-48.
Lucky TT, Seed CR, Keller A et al (2013). Trends in transfusion-transmissible infections among Australian blood donors from 2005 to 2010. Transfusion, 53(11):2751-2762.
Khedmat H, Alavian SM, Miri SM, et al (2009). Trends in seroprevalence of hepatitis B, hepatitis C, HIV, and syphilis infections in Iranian blood donors from 2003 to 2005. Hepat Mon, 24-28.
Soldan K, Barbara J, Ramsay M et al (2003). Estimation of the risk of hepatitis B virus, hepatitis C virus and human immunodeficiency virus infectious donations entering the blood supply in England, 1993–2001. Vox Sang, 84(4):274-286.
Zou S, Notari I, Edward P et al (2004). Patterns of age- and sex- specific prevalence of major blood-borne infections in United States blood donors, 1995 to 2002: American Red Cross blood donor study. Transfusion, 44(11):1640-1647.
Gurol E, Saban C, Oral O et al (2006). Trends in hepatitis B and hepatitis C virus among blood donors over 16 years in Turkey. Eur J Epidemiol, 21(4):299-305
Bhattacharya P, Chandra PK, Datta S et al (2007). Significant increase in HBV, HCV, HIV and syphilis infections among blood donors in West Bengal, Eastern India 2004-2005: exploratory screening reveals high frequency of occult HBV infection. World J Gastroenterol, 13(27):3730-3733.
Zali MR (1996). Epidemiology of hepatitis B in the Islamic Republic of Iran. Eeast Mediterr Health J, 2(2):290-298.
Merat S, Rezvan H, Nouraie M et al (2009). The prevalence of hepatitis B surface antigen and anti-hepatitis B core antibody in Iran: a population-based study. Arch Iran Med, 12(3):225-231.
Nalini G, Vijay K, Amarjit K (2004). Seroprevalence of HIV, HBV, HCV and syphilis in voluntary blood donors. Indian J Med Sci, 58(6):255-257.
Jehangir W, Ali F, Shahnawaz U et al (2006). Prevalence of hepatitis B, C and HIV in blood donors of South Punjab. Esculapio, 2:6-7.
Salawu L, Bolarinwa R, Adegunloye A et al (2010). HBsAg, anti-HCV, anti-HIV and VDRL in blood donors: Prevalence and trends in the last three and a half years in a tertiary health care facility in Ile-Ife, Nigeria. International Journal of Medicine and Medical Sciences, 2(11):335-341.
Sallam TA, Tong CY, Cuevas LE et al (2003). Prevalence of blood-borne viral hepatitis in different communities in Yemen. Epidemiol Infect, 131(01):771-775.
Dessie A, Abera B, Wale F (2007). Seroprevalence of major blood-borne infections among blood donars at Felege Hiwot referral hospital, Northwest Ethiopia. Ethiopian Journal of Health Development, 21(1):68-69.
Polizzotto MN, Wood EM, Ingham H et al (2008). Reducing the risk of transfusion-transmissible viral infection through blood donor selection: the Australian experience 2000 through 2006. Transfusion, 48(1):55-63.
Supplies S: Focusing on epidemiology. Annual Review from the NHS Blood and Transplant/Health Protection Agency Colindale Epidemiology Unit 2010.
Alavian S-M, Adibi P, Zali M-R (2005). Hepatitis C virus in Iran: Epidemiology of an emerging infection. Arch Iranian Med, 8(2):84-90.
Taherkhani R, Farshadpour F (2015). Epidemiology of hepatitis C virus in Iran. World J Gastroenterol, 21(38):10790-10810.
Khodabandehloo M, Roshani D, Sayehmiri K (2013). Prevalence and trend of hepatitis C virus infection among blood donors in Iran: A systematic review and meta-analysis. J Res Med Sci, 18(8):674-682.
Mbanya DN, Takam D, Ndumbe PM (2003). Serological findings amongst first-time blood donors in Yaoundé, Cameroon: is safe donation a reality or a myth? Transfus Med, 13(5):267-273.
O'Brien SF, Fan W, Xi G et al (2008). Declining hepatitis C rates in first-time blood donors: insight from surveillance and case-control risk factor studies. Transfusion, 48(5):902-909.
Zou S, Dorsey KA, Notari EP et al (2010). Prevalence, incidence, and residual risk of human immunodeficiency virus and hepatitis C virus infections among United States blood donors since the introduction of nucleic acid testing. Transfusion, 50(7):1495-1504.
Ameen R, Sanad N, Al-Shemmari S et al (2005). Prevalence of viral markers among first-time Arab blood donors in Kuwait. Transfusion, 45(12):1973-1980.
Pallavi P, Ganesh C, Jayashree K et al (2011). Seroprevalence and trends in transfusion transmitted infections among blood donors in a university hospital blood bank: a 5 year study. Indian J Hematol Blood Transfus, 27(1):1-6.
Van der Bij AK, Coutinho RA, Van der Poel CL (2006). Surveillance of risk profiles among new and repeat blood donors with transfusion-transmissible infections from 1995 through 2003 in the Netherlands. Transfusion, 46(10):1729-1736.
Brant LJ, Reynolds C, Byrne L et al (2011). Hepatitis B and residual risk of infection in English and Welsh blood donors, 1996 through 2008. Transfusion,51(7):1493-1502.
Lattimore S, Wickenden C, Brailsford SR (2015). Blood donors in England and North Wales: demography and patterns of donation. Transfusion, 55(1):91-99.
Farzadegan H, Harbour C, Ala F (1979). The prevalence of hepatitis B surface antigen and its antibody in blood donors and high risk groups in Iran. Vox Sang, 37(3):182-186.
Massarrat M-S, Tahaghoghi-Mehrizi S (2002). Iranian national health survey: a brief report. Arch Iran Med, 5(2):73-79.
Likatavicius G, Hamers FF, Downs AM et al (2007). Trends in HIV prevalence in blood donations in Europe, 1990–2004. AIDS, 21(8):1011-1018.
Yildiz SM, Candevir A, Kibar F et al (2015). Hepatitis B, Hepatitis C, Human immunodeficiency virus and syphilis frequency among blood donors: A single center study. Transfus Apher Sci, 53(3):308-314.
| Files | ||
| Issue | Vol 47 No 7 (2018) | |
| Section | Original Article(s) | |
| Keywords | ||
| Transfusion transmissible infections Prevalence Trend Iran | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
